Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Liberia launches its Sovereign Carbon Initiative following in the footsteps of Djibouti and Gabon
- Akinwumi Adesina gets back in the saddle
- Tunisia: Attijari Leasing Board of Directors proposes the distribution of a total dividend of 6.050 million dinars for the 2025 fiscal year
- BEAC fully committed to repatriating export revenues
- Tunisia: Attijari Leasing records increased profit and announces dividends
- Islamic Finance and PPP: Issa Malgoubri’s suggestions for mobilizing resources
- Basel II/III and Financing the Economy in the UEMOA: Successfully Transitioning to “Basel 4”
- Rating: Bloomfield maintains Orange Côte d’Ivoire’s long and short term ratings unchanged
